Company Filing History:
Years Active: 2003-2013
Title: Ivo Dorossiev: Innovator in Pharmaceutical Compositions
Introduction
Ivo Dorossiev is a notable inventor based in Herzlia, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical compositions. With a total of 3 patents to his name, Dorossiev's work focuses on enhancing the stability of active components in pharmaceutical formulations.
Latest Patents
Dorossiev's latest patents include innovative pharmaceutical compositions that contain 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids. These compositions are designed to maintain excellent storage stability, even when the active components are prone to degradation in acidic environments. The stabilized pharmaceutical compositions utilize ring-opened 7-substituted-3,5-dihydroxyheptanoic or ring-opened 7-substituted-3,5-dihydroxyheptenoic acids, or their pharmaceutically acceptable salts, as active components. They also incorporate a stabilizing effective amount of at least one amido-group containing polymeric compound or at least one amino-group containing polymeric compound. Notably, these compositions do not require additional stabilizers, which enhances their efficacy. Furthermore, the compositions may include various pharmaceutically acceptable excipients to aid in the formulation of tablet dosage forms.
Career Highlights
Ivo Dorossiev is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions that address critical challenges in drug formulation and stability.
Collaborations
Dorossiev collaborates with Michael Fox, contributing to the advancement of pharmaceutical technologies and innovations.
Conclusion
Ivo Dorossiev's contributions to the field of pharmaceuticals through his patents and work at Teva Pharmaceutical Industries Limited highlight his commitment to improving drug stability and efficacy. His innovative approaches continue to influence the pharmaceutical industry positively.